Developed the global manufacturing strategy for a leading international pharmaceutical company. This included a decision logic to streamline the global plant portfolio and a recommendation balancing economic, regulatory and marketing aspects. The result was a reduction of three manufacturing sites, the successful transfer of products and the remaining, higher utilized plants dedicated to specific roles within a global network.